- Previous Rank390
- Revenues ($M)$9,739.00
- Revenue Percent Change41.6%
- Profits ($M)$1,309.00
- Profits Percent Change1038.30%
- Assets ($M)$22,742.00
- Employees55,000
- Market Value — as of March 29, 2018 ($M)$20,433.40
The global contract-research firm conducts clinical trials and other activities for health care companies.
Looking for leads, investment insights, or competitive intelligence?Buy Now
Company Info
| CEO | Ari Bousbib |
| CEO Title | Chairman, President & Chief Executive Officer |
| Sector | Health Care |
| Industry | Health Care: Pharmacy and Other Services |
| HQ Location | Durham, N.C. |
| Website | http://www.iqvia.com |
| Years on Fortune 500 List | 5 |
| Employees | 55,000 |
Changed name from Quintiles IMS Holdings, Nov. 6, 2017.
IQVIA Holdings Rank History
placeholder
Key Financials (Last Fiscal Year)
| $ millions | % change | |
|---|---|---|
| Revenues ($M) | $9,739.00 | 41.6% |
| Profits ($M) | $1,309.00 | 1038.30% |
| Assets ($M) | $22,742.00 | - |
| Total Stockholder Equity ($M) | $8,109.00 | - |
| Market Value — as of March 29, 2018 ($M) | $20,433.40 | - |
Profit Ratios
| Profit as % of Revenues | 13.4% |
| Profits as % of Assets | 5.8% |
| Profits as % of Stockholder Equity | 16.1% |
Earnings Per Share (Last Fiscal Year)
| Earnings Per Share ($) | 5.88 |
| EPS % Change (from 2016) | 673.7% |
| EPS % Change (5 year annual rate) | - |
| EPS % Change (10 year annual rate) | - |
Total Return
| Total Return to Investors (2017) | 28.7% |
| Total Return to Investors (5 year, annualized) | - |
| Total Return to Investors (10 year, annualized) | - |
